260 related articles for article (PubMed ID: 21776018)
1. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.
Kaur T; Mukherjea D; Sheehan K; Jajoo S; Rybak LP; Ramkumar V
Cell Death Dis; 2011 Jul; 2(7):e180. PubMed ID: 21776018
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
[TBL] [Abstract][Full Text] [Related]
3. NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss.
Mukherjea D; Jajoo S; Sheehan K; Kaur T; Sheth S; Bunch J; Perro C; Rybak LP; Ramkumar V
Antioxid Redox Signal; 2011 Mar; 14(6):999-1010. PubMed ID: 20712533
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.
Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V
Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809
[TBL] [Abstract][Full Text] [Related]
5. Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Whitworth C; Bunch JR; Turner JG; Rybak LP; Ramkumar V
J Neurosci; 2008 Dec; 28(49):13056-65. PubMed ID: 19052196
[TBL] [Abstract][Full Text] [Related]
6. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
[TBL] [Abstract][Full Text] [Related]
7. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea.
Bhatta P; Dhukhwa A; Sheehan K; Al Aameri RFH; Borse V; Ghosh S; Sheth S; Mamillapalli C; Rybak L; Ramkumar V; Mukherjea D
Sci Rep; 2019 Mar; 9(1):4131. PubMed ID: 30858408
[TBL] [Abstract][Full Text] [Related]
8. siRNA-mediated knock-down of NOX3: therapy for hearing loss?
Rybak LP; Mukherjea D; Jajoo S; Kaur T; Ramkumar V
Cell Mol Life Sci; 2012 Jul; 69(14):2429-34. PubMed ID: 22562580
[TBL] [Abstract][Full Text] [Related]
9. Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity.
Al Aameri RFH; Alanisi EMA; Oluwatosin A; Al Sallami D; Sheth S; Alberts I; Patel S; Rybak LP; Ramkumar V
Front Immunol; 2023; 14():1125948. PubMed ID: 37063917
[TBL] [Abstract][Full Text] [Related]
10. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
Shin YS; Song SJ; Kang SU; Hwang HS; Choi JW; Lee BH; Jung YS; Kim CH
Neuroscience; 2013 Mar; 232():1-12. PubMed ID: 23246618
[TBL] [Abstract][Full Text] [Related]
11. Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss.
Dhukhwa A; Al Aameri RFH; Sheth S; Mukherjea D; Rybak L; Ramkumar V
Sci Rep; 2021 Apr; 11(1):8116. PubMed ID: 33854102
[TBL] [Abstract][Full Text] [Related]
12. Apelin-13 protects against cisplatin-induced ototoxicity by inhibiting apoptosis and regulating STAT1 and STAT3.
Yin H; Sun Y; Ya B; Guo Y; Zhao H; Zhang L; Wang F; Zhang W; Yang Q
Arch Toxicol; 2023 Sep; 97(9):2477-2493. PubMed ID: 37395757
[TBL] [Abstract][Full Text] [Related]
13. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of signal transducer and activator of transcription 1 reduces bortezomib-mediated apoptosis in cancer cells.
Kao C; Chao A; Tsai CL; Lin CY; Chuang WC; Chen HW; Yen TC; Wang TH; Lai CH; Wang HS
Cell Death Dis; 2013 Feb; 4(2):e512. PubMed ID: 23449448
[TBL] [Abstract][Full Text] [Related]
15. Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity.
Kim HJ; Lee JH; Kim SJ; Oh GS; Moon HD; Kwon KB; Park C; Park BH; Lee HK; Chung SY; Park R; So HS
J Neurosci; 2010 Mar; 30(11):3933-46. PubMed ID: 20237264
[TBL] [Abstract][Full Text] [Related]
16. Protective Effect of Avenanthramide-C on Auditory Hair Cells against Oxidative Stress, Inflammatory Cytokines, and DNA Damage in Cisplatin-Induced Ototoxicity.
Umugire A; Nam YS; Nam YE; Choi YM; Choi SM; Lee S; Cho JH; Cho HH
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769271
[TBL] [Abstract][Full Text] [Related]
17. Transient Receptor Potential Channels and Auditory Functions.
Ramkumar V; Sheth S; Dhukhwa A; Al Aameri R; Rybak L; Mukherjea D
Antioxid Redox Signal; 2022 Jun; 36(16-18):1158-1170. PubMed ID: 34465184
[No Abstract] [Full Text] [Related]
18. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
19. Nox3-Derived Superoxide in Cochleae Induces Sensorineural Hearing Loss.
Mohri H; Ninoyu Y; Sakaguchi H; Hirano S; Saito N; Ueyama T
J Neurosci; 2021 May; 41(21):4716-4731. PubMed ID: 33849947
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
